Blog

Guide leverages Stream Hatchet’s influencer analytic and management capabilities to help creators understand campaigns and tactics to reach 
live streaming audiences

The report highlights opportunities to capitalize on the estimated $32.6 billion global market in 2025 for influencer marketing

View the report: Expert Influencer Marketing Tips – Free Download

FRISCO, TEXAS / ACCESS Newswire / May 22, 2025 / Stream Hatchet, the leading provider of data analytics for live streaming, influencer and gaming ecosystems and wholly-owned subsidiary of GameSquare Holdings (NASDAQ:GAME), (“GameSquare”, or the “Company”), has released an influencer marketing guide to help creators reach and track live streaming audiences.

The report leverages the combined expertise of Stream Hatchet and Sideqik, another GameSquare subsidiary, which recently launched influencer marketing campaign management tools as part of their integrated solutions.

Influencer marketing has surged in popularity. According to Influencer Marketing Hub the global influencer marketing market has grown from $1.4 billion in 2014 to a projected $32.6 billion in 2025. More than 80% of marketers view influencer marketing as a highly effective strategy, with 64% of brands planning to run influencer campaigns in 2025. Among the various influencer types, streamers represent an emerging category, offering exciting opportunities for innovative campaign strategies. In 2024, viewers consumed over 32.5 billion hours of livestreamed content across all platforms.

With deep expertise in analyzing, managing, and executing live streaming campaigns, Stream Hatchet and Sideqik bring valuable insights to brands and creators. The newly released guide highlights the rising importance of influencer marketing, offers a step-by-step roadmap for campaign execution, and includes real-world case studies. Special attention is given to the unique opportunities in live streaming, showcasing how cutting-edge activations are changing the way brands engage with new players, buyers, and consumers.

“GameSquare’s Stream Hatchet and Sideqik business units have created a powerful end-to-end influencer marketing solution,” said Justin Kenna, CEO of GameSquare. “They are well-positioned to help brands and video game publishers succeed in the rapidly expanding live streaming marketplace.”

Access to the report is available at Expert Influencer Marketing Tips – Free Download

For more information on Stream Hatchet and insight into the esports and streaming markets, please visit their website at www.streamhatchet.com.

About GameSquare Holdings, Inc.

GameSquare’s (NASDAQ: GAME) mission is to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Our next generation media, entertainment, and technology capabilities drive compelling outcomes for creators and maximize our brand partners’ return on investment. Through our purpose-built platform, we provide award winning marketing and creative services, offer leading data and analytics solutions, and amplify awareness through FaZe Clan Esports, one of the most prominent and influential gaming organizations in the world. With one of the largest gaming media networks in North America, as verified by Comscore, we are reshaping the landscape of digital media and immersive entertainment. GameSquare’s largest investors are Dallas Cowboys owner Jerry Jones and the Goff family.

To learn more, visit www.gamesquare.com.

About Stream Hatchet

Stream Hatchet delivers real-time, actionable insights into the gaming and live-streaming ecosystem across 16 platforms. From performance benchmarking to campaign ROI and influencer intelligence, Stream Hatchet empowers game publishers, brands, agencies, and tournament organizers with the industry’s most granular data and reporting tools.

For more information visit www.streamhatchet.com.

Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Company’s and FaZe Media Inc.’s future performance, revenue, growth and profitability; and the Company’s and FaZe Media’s ability to execute their business plans. These forward-looking statements are provided only to provide information currently available to us and are not intended to serve as and must not be relied on by any investor as, a guarantee, assurance or definitive statement of fact or probability. Forward-looking statements are necessarily based upon a number of estimates and assumptions which include, but are not limited to: the Company’s and FaZe Media’s ability to grow their business and being able to execute on their business plans, the Company being able to complete and successfully integrate acquisitions, the Company being able to recognize and capitalize on opportunities and the Company continuing to attract qualified personnel to supports its development requirements. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the Company’s ability to achieve its objectives, the Company successfully executing its growth strategy, the ability of the Company to obtain future financings or complete offerings on acceptable terms, failure to leverage the Company’s portfolio across entertainment and media platforms, dependence on the Company’s key personnel and general business, economic, competitive, political and social uncertainties. These risk factors are not intended to represent a complete list of the factors that could affect the Company which are discussed in the Company’s most recent MD&A. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. GameSquare assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Corporate Contact

Lou Schwartz, President
Phone: (216) 464-6400
Email: ir@gamesquare.com

Investor Relations

Andrew Berger
Phone: (216) 464-6400
Email: ir@gamesquare.com

Media Relations

Chelsey Northern / The Untold
Phone: (254) 855-4028
Email: pr@gamesquare.com

SOURCE: GameSquare Holdings, Inc.

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / May 22, 2025 / AstraBit has officially launched its Elite Trader Program, a system built to bring trust, accountability, and verified performance to the world of crypto copy trading.

From a simple, single interface, experienced traders can now trade across multiple integrated centralized and decentralized exchanges simultaneously, monetizing their expertise in the digital asset space. Followers can subscribe and automatically mirror those trades through the integrated exchange of their choice.

AstraBit is offering a new model prioritizing efficiency, fairness, transparency, and structure, because we believe innovation should not be lawless. The Elite Trader Program gives vetted, approved, and experienced traders the ability to share and monetize their trades, and allows subscribers to potentially benefit from their knowledge and experience.

“Our goal is to make crypto investment and copy trading accessible and accountable,” said Cam Paulding, CMO of AstraBit. “With AstraBit approved Elite Traders, subscribers aren’t blindly copying ‘finfluencers’ with potential ulterior motives. Subscribers can invest collaboratively with vetted, verified traders who have past track records of success.”

Elite Traders must complete a rigorous application process and provide a verifiable trading history that will be analyzed by AstraBit’s portfolio system and evaluated by our team of licensed professionals. AstraBit’s goal is to ensure risk/return parameters are aligned with various investor objectives. Once approved, Elite Traders receive access to a personal admin dashboard where they can build, manage, and offer their services to subscribers.

Members benefit from AstraBit’s curated marketplace of experienced traders and strategists. Every Elite Trader will undergo thorough review, to help give subscribers confidence that they’re collaborating with serious traders, not anonymous accounts with no accountability.

“Elite Trader reflects what AstraBit stands for: transparency, credibility, and giving our members the tools to help them make more informed decisions,” said Nicholas Bentivoglio, CEO and Co-Founder of AstraBit. “It’s time for this space to mature and be accountable.”

AstraBit is designed to give members and their financial professionals the tools and confidence to engage with the crypto space in a secure and structured way designed to bring integrity and opportunity to everyone.

The AstraBit Elite Trader Program is now accepting applications. To learn more or apply, visit https://elite.astrabit.io.

Disclaimer:
Crypto trading involves significant risk and may result in the loss of your capital. Past performance does not guarantee future results. AstraBit does not make any representations or warranties regarding expected returns or outcomes from the use of its platform or copy trading features. Users should conduct their own research and consider consulting with a licensed financial professional before making trading decisions or using any AstraBit product or service. Any return data provided by AstraBit is for informational processing only, and has not been audited by an independent third party.

About AstraBit:
AstraBit is a US-based, veteran owned and operated automated crypto trading, staking and portfolio management platform that connects to both centralized and decentralized exchanges. Built for investors and traders of all experience levels, AstraBit offers a unified system for bots, analytics, copy trading and more. AstraBit’s core mission is focused on transparency, integrity, and accountability, because we believe innovation should not be lawless.

Press Contact:
Cam Paulding
Chief Marketing Officer, AstraBit
Email: marketing@astrabit.io
Website: https://astrabit.io

SOURCE: AstraBit

View the original press release on ACCESS Newswire

VANCOUVER, BC / ACCESS Newswire / May 22, 2025 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that the Membership Interest Purchase Agreement (the “MIPA”) entered into by its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist (the “Seller”) to acquire his nine percent (9%) of the issued and outstanding membership interests of Alternative Medicine Association LC (“AMA”) has been amended (refer to news release dated April 8, 2024).

Under the amended terms of the MIPA, the purchase price (the “Purchase Price”) for the Membership is a total of USD$50,00, payable to the Seller USD$25,000 in cash and USD$25,000 through the issuance of shares of common stock of 1933 Industries (the “Shares”). The final number of Shares to be issued to the Seller is 5,503,450 as determined via the 10 day VWAP price of the Shares on November 27, 2024, being the date the transactions contemplated by the MIPA (the “Transaction”) were approved by the Nevada Cannabis Compliance Board.

The Shares are subject to a hold period in Canada expiring on October 1, 2025. Additional restrictions will apply pursuant to the Securities Act of 1933, as amended.

The parties have set the closing date for the Transaction as May 30, 2025. With the completion of the MIPA, FN Pharmaceuticals owns 100% of the membership interest in AMA, the Company’s cultivation and production subsidiary.

As Mr. Zobrist was a senior officer of the Company at the time the MIPA was entered into, he is a “related party” to the Company within the meaning of Multilateral Instrument 61-101- Protection of Minority Security Holders in Special Transactions (“MI 61-101”). As such, the transaction constitutes a “related party transaction” within the meaning of MI 61-101.

The Company intends to rely on exemptions from formal valuation and the minority shareholder approval requirements of MI 61-101 found in sections 5.5(a) and 5.7(1)(a) of MI 61-101 as the fair market value of the transaction does not constitute more than the 25% of the Company’s market capitalization.

About 1933 Industries Inc.

1933 Industries is a Nevada-based licensed wholesale producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company’s 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com

For further information please contact:
Alexia Helgason, VP, Investor Relations
604-728-4407
alexia@1933industries.com

Brian Farrell, Chairman and CEO
brian@1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / VIPRE Security Group (VIPRE), a leading global provider of cybersecurity solutions and a Ziff Davis company, today announced the strategic acquisition of Forensic and Compliance Systems (FCS), including its established Cryoserver and Solar Archive brands. This acquisition significantly enhances VIPRE’s email security portfolio, reinforcing its commitment to delivering comprehensive data protection and compliance solutions for businesses and Managed Service Providers (MSPs) globally.

Based in the UK and Dublin, FCS brings a strong legacy in integrated email archiving solutions since its founding in 2006. Its two key brands are:

• Cryoserver: A robust and user-friendly email archiving solution, available both on-premise and in the cloud, serving a diverse customer base across Europe and North America. Known for its strong security and comprehensive features, Cryoserver ensures secure storage and easy retrieval of email communications critical for compliance, eDiscovery, and business continuity.

• Solar Archive: A globally recognized white-label, cloud-based email archiving solution specifically designed for MSPs and Original Equipment Manufacturers (OEMs). Solar Archive offers a scalable, efficient, and low-maintenance platform, empowering partners to deliver premier archiving services under their own brand.

This strategic acquisition significantly deepens VIPRE’s suite of cyber security and compliance offerings, leveraging FCS’s proven technology. The acquisition also presents a significant opportunity to expand VIPRE’s MSP network by introducing its portfolio of email and endpoint security, and security training solutions to FCS’s partner ecosystem. Looking ahead, VIPRE is committed to accelerating the product roadmaps for Cryoserver and Solar Archive, making strategic investments in their continued growth. This will lead to a more compelling offering for customers and partners, significantly strengthening our overall value proposition.

“This acquisition marks a significant milestone in our mission to provide the most comprehensive and secure email archiving solutions available,” stated Usman Choudhary, General Manager of VIPRE Security Group. “By uniting Cryoserver’s direct-to-market strength with Solar Archive’s innovative partner-centric platform, VIPRE is uniquely positioned to address the evolving compliance, security, and operational demands of organizations and MSPs worldwide.”

About VIPRE Security Group

VIPRE Security Group, part of Ziff Davis, Inc., is a leading provider of internet security solutions purpose-built to protect businesses, solution providers, and home users from costly and malicious cyber threats. With more than 25 years of industry expertise, VIPRE is one of the world’s largest threat intelligence clouds, delivering exceptional protection against today’s most aggressive online threats. Its award-winning software portfolio includes next-generation antivirus endpoint cloud solutions, advanced email security products, along with threat intelligence for real-time malware analysis, and security awareness training for compliance and risk management. VIPRE solutions deliver easy-to-use, comprehensive layered defense through cloud-based and server security, with mobile interfaces that enable instant threat response.

The group operates under various brands, including VIPRE®, StrongVPN®, IPVanish®, Inspired eLearning®, Livedrive®, and SugarSync®. www.VIPRE.com.

CONTACT:

Scott Rupp
+19414487566

SOURCE: VIPRE Security Group

View the original press release on ACCESS Newswire

A new Field Operations & Retail Channel Engagement activation team has launched in Las Vegas to onboard 200 new stores and establish a scalable model for nationwide expansion.

LAS VEGAS, NV / ACCESS Newswire / May 22, 2025 / GPO Plus, Inc. (OTCQB:GPOX), an AI-powered distributor revolutionizing product delivery to gas stations and convenience stores through its innovative, tech-driven Direct Store Delivery (DSD) model, today announced the deployment of its Field Operations & Retail Channel Engagement sales team (“G-FORCE”) in Las Vegas to drive new retail account growth and deepen market penetration.

G-FORCE is a field-based sales team designed to open new accounts, accelerate product placement, collect data at the store level, and increase revenue. The initial goal is to activate 200 new retail locations across the Las Vegas metropolitan area.

This hands-on activation initiative is part of a larger, coordinated growth strategy now being executed following a strong Q3, where GPOX reported a 30% reduction in operating expenses and a significant increase in gross margins from 15% to 28%. With operations streamlined and margins improving, the company is entering a new expansion phase, and a field activation team is a key growth lever within that framework.

“The field activation team is a critical component of our national rollout strategy,” said Brett H. Pojunis, CEO of GPO Plus, Inc. “This program allows us to scale efficiently, connect directly with high-value retail partners, and apply what we learn to expand rapidly into new markets. Combined with our call center, digital ordering portal, and improved logistics, this strategy gives us a clear edge to open new markets and execute our billion-dollar vision.“

This initiative is designed as a repeatable and scalable model. By deploying trained field teams in densely populated urban markets, GPOX bypasses traditional distribution bottlenecks and establishes direct relationships with independent retailers. The G-Force teams handle store onboarding, product education, merchandising, and order placement-closing the loop between sales strategy and in-store execution. Once the Las Vegas operation reaches maturity, GPOX plans to replicate this model in additional key markets as part of a structured national rollout.

The Las Vegas activation also complements GPOX’s recently launched call center and DISTRO+ Wholesale Portal, both designed to increase velocity and reach across sales channels. Together, these initiatives significantly expand GPOX’s total addressable market (TAM) and provide the scalable infrastructure needed to drive national growth.

To learn more, visit GPOPlus.com.

Connect with us on social media to view live video updates, content, and general information about GPOX: https://gpoplus.com/social.

About GPOPlus+ (GPOX)
GPOX is an AI-powered Distributor revolutionizing the future of distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model. Our goal is clear and ambitious: “to build the largest nationwide DSD distribution company servicing gas stations, convenience stores, and beyond.” Our technology-driven AI network, featuring strategically placed Regional Hubs and Mini Hubs, is designed to optimize efficiency and maximize reach. Central to our operations is our in-house AI technology platform, PRISM+. Designed to streamline the distribution process, PRISM+ supports efficient delivery, inventory management, data analytics, and overall operational excellence, enabling us to reliably and effectively meet the dynamic needs of our partners. Our mission is to consolidate the fragmented market segment managed by numerous regional vendors. Our dedication to excellence is evident in our product selection process, where we align offerings with consumer demand and partner with top-tier vendors and brands, ensuring our portfolio remains diverse and highly profitable.

For more information, please visit www.GPOPlus.com.

Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include statements regarding expected financial performance and growth information relating to future events. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its officers and managers, and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company’s need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company’s products, and other risks that are detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as “may,” “will,” “can” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “seek,” “estimate,” “continue,” “plan,” “point to,” “project,” “predict,” “could,” “intend,” “target,” “potential,” and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reflected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reflect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company’s actual results may vary significantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties affecting GPO Plus, Inc. GPOX, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Company Contacts:
GPOX Shareholder Success Team:
Brett H. Pojunis, CEO
Email: ir@gpoplus.com
Shareholder’s Line: 855.935.GPOX (4769)

SOURCE: GPO Plus, Inc.

View the original press release on ACCESS Newswire

Expanding to Serve More Customers Across the Denver Metro Area

LAKEWOOD, CO / ACCESS Newswire / May 22, 2025 / Midwest Plumbing Co. LLC, a trusted name in residential and commercial plumbing services, is proud to announce the grand opening of its second office in Lakewood, Colorado. This exciting expansion marks another milestone in the company’s mission to provide high-quality plumbing solutions with a customer-first approach across the Denver metro area.

Founded in 2021 by James Stanley, a seasoned industry professional with over a decade of hands-on plumbing experience, Midwest Plumbing has quickly become known for its fast response times, skilled technicians, and exceptional customer care. Headquartered in Westminster, Colorado, the company was built on James’s deep-rooted commitment to the local community and his vision of creating a plumbing company driven by integrity and expertise.

“Opening a second location in Lakewood allows us to better serve customers on the west side of Denver with faster, more convenient service,” said Stanley. “Our team is passionate about doing the job right the first time, and we’re excited to bring that same level of quality to even more homes and businesses.”

Local Plumbing Experts in Lakewood, CO
Midwest Plumbing’s Lakewood office will offer the same same-day plumbing services that have earned the company a stellar reputation in Westminster and surrounding areas. Services include:

• Faucet and Fixture Repairs – From leaky faucets to malfunctioning toilets, our licensed plumbers can restore or replace plumbing fixtures quickly and affordably.

• Leaking Pipe Detection and Repair – Whether hidden behind walls or beneath foundations, our expert technicians can locate and fix plumbing leaks before they become major issues.

• Gas Line Services – Safe, code-compliant gas line installation and repair for home appliances, water heaters, and more.

• Water Heater Installation & Repair – Full-service support for electric and gas water heaters, including replacements and energy-efficient upgrades.

• Garbage Disposal Services – We install and repair garbage disposals with the horsepower to handle your kitchen’s needs.

• Water Filtration System Installation – Enjoy cleaner, better-tasting water with point-of-use or whole-home filtration systems tailored to your property.

Midwest Plumbing takes pride in its team of meticulously vetted technicians who are not only licensed and insured, but also share the company’s strong values of honesty, reliability, and professionalism.

Why Choose Midwest Plumbing?
With an emphasis on customer satisfaction, Midwest Plumbing stands apart through personalized service and attention to detail. Whether you’re dealing with an emergency leak, planning a plumbing remodel, or simply looking for a reliable local plumber in Lakewood, CO, Midwest Plumbing is now just around the corner.

“Our goal has always been to treat our customers like neighbors – because they are,” added Stanley. “With this expansion, we’re doubling down on our promise to provide fast, friendly, and effective plumbing service throughout Colorado.”

For more information or to schedule a service call, visit Midwest Plumbing’s Lakewood service page or call (720) 648-0613.

ABOUT MIDWEST PLUMBING CO.
Founded in 2021, Midwest Plumbing Co. LLC is a locally owned plumbing company headquartered in Westminster, Colorado. Led by James Stanley, the company specializes in residential and commercial plumbing services, including same-day service for leak repair, gas line installation, water heater service, and more. With a commitment to quality craftsmanship and outstanding customer care, Midwest Plumbing continues to grow as a trusted partner for homeowners and businesses across the Front Range. For more information visit: https://midwestplumbingco.com/

SOURCE: Midwest Plumbing Co.

View the original press release on ACCESS Newswire

Dateline Resources Limited (ASX:DTR)(OTC PINK:DTREF) has updated its Scoping Study for the 100% owned Colosseum Gold Project, increasing the gold price assumption from $2,200/oz in the October 2024 Project Definition Study (PDS) to $2,900/oz for the Bankable Feasibility Study (BFS), reflecting recent gold price performance averaging $3,000/oz in 2025 and a long-term consensus forecast. With all other production assumptions unchanged, this results in a 32% increase in sales revenue, a 208% increase in net revenue before tax, a 134% increase in NPV to US$550 million from US$235 million (6.5% discount), and a 96% increase in before-tax internal rate of return (IRR) to 61% from 31%. These outcomes, at a Scoping Study level of confidence, highlight the project’s robust potential as it advances into the BFS.

Table 1: Colosseum Gold Mine Scoping Study – Estimates of Inputs and Outcomes

Note: The following table should be read in conjunction with the cautionary statement below

*** The results presented in Table 1 are estimates only, based on an estimated level of accuracy of +/- 35%, as per the Cautionary Statement below**

Cautionary Statement

The Project Definition Study was undertaken to assess the viability of developing the Colosseum Gold Project by constructing an open cut mine ± underground mine and processing facility to produce gold doré.

It is a preliminary technical and economic study of the potential viability of the Colosseum Project. It is based on technical and economic assessments that are not sufficient to support the estimation of Ore Reserves. Further exploration and evaluation work and appropriate studies are required before Dateline will be in a position to estimate any Ore Reserves or to provide any assurance of an economic development case.

The Study is based on the material assumptions highlighted in the announcement “Colosseum Scoping Study Delivers Positive Outcomes,” 23 October 2024. While the Company considers all the material assumptions to be based on reasonable grounds, there is no certainty that they will prove to be correct or that the range of outcomes indicated by the Study will be achieved.

There is a low level of geological confidence associated with Inferred Mineral Resources, and there is no certainty that further exploration work will result in the determination of Indicated or Measured Mineral Resources or that the production target itself will be realized.

The Study is based on the June 2024 Mineral Resource Estimate, is based on low-level technical and economic assessments, and is insufficient to support the estimation of Ore Reserves or to provide assurance of an economic development case at this stage, or to provide certainty that the conclusions of the Study will be realized.

The Study has been completed to a level of accuracy of +/-35% in line with industry standard accuracy for this stage of development. The Company has reasonable grounds for disclosing a Production Target, given that in the first five years of production, 89% of the mill feed is scheduled from the Measured and Indicated Resource category, which exceeds the economic payback period for the Project by 1.75 years.

Approximately 55% of the Life of Mine Production Target is in the Measured Mineral Resource category, 26% is in the Indicated Mineral Resource category, and 19% is in the Inferred Mineral Resource category. There is a lower level of geological confidence associated with Inferred Mineral Resources, and while the Company considers all the material assumptions in this Study to be based on reasonable grounds, there is no certainty that they will prove to be correct or that the range of outcomes indicated will be achieved.

The Mineral Resources underpinning the production target in the Study have been prepared by a Competent Person in accordance with the requirements of the Australasian Code for Reporting of Exploration Results, Mineral Resources, and Ore Reserves (JORC Code (2012)). The Competent Person’s Statement is found in the Mineral Resources section of the Study. For full details of the Mineral Resource Estimate, please refer to Dateline’s ASX Announcement dated 6 June 2024.

Dateline confirms that it is not aware of any new information or data that materially affects the information included in that release. All material assumptions and technical parameters underpinning the estimates in that Announcement continue to apply and have not materially changed.

Note that unless otherwise stated, all currency in this Announcement is US dollars.

About Dateline Resources Limited

Dateline Resources Limited (ASX: DTR) is an Australian publicly listed company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.

The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold Mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47g/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated, and 364koz @ 1.10g/t Au (33%) as Inferred.

The Colosseum is located less than 10km north of the Mountain Rare Earth mine. Work has commenced on identifying the source of the mantle-derived rocks that are associated with carbonatites and are located at Colosseum.

Scoping Study Authors & Competent Person Statements

This Scoping Study is as defined in Clause 38 of the JORC Code 2012. It refers to the Mineral Resource Estimate announced by Dateline Resources Limited (DTR) on 6 June 2024, but the Production Targets presented do not constitute Ore Reserves as defined in the JORC Code 2012.

Apart from the Mineral Resource Estimate, the PDS was completely compiled by Australian Mine Design and Development Pty Ltd (AMDAD) with information supplied by Dateline, generated by AMDAD, or publicly sourced.

The principal author of the report and supervisor of the work conducted by AMDAD is Mr. John Wyche BE(Min Hon) BComm FAusIMM CP. Mr. Wyche is a Fellow of the Australasian Institute of Mining and Metallurgy. He has 37 years of relevant experience in hard rock gold mining.

Mr. Wyche does not hold shares or any other form of equity in Dateline Resources Limited.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or future performance and include, but are not limited to, statements regarding the potential of the Colosseum Project, the expected benefits of the OTCQB listing, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on the company’s current expectations, estimates, and projections, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: fluctuations in the prices of gold and rare earth elements; changes in regulatory requirements or permitting processes; geological or technical challenges in exploration and development; market conditions affecting the company’s ability to raise capital; environmental or social factors impacting operations; risks associated with the OTCQB listing process or trading on a new market; environmental and permitting risks associated with operating in a national preserve; uncertainty regarding the delineation of a mineable rare earth elements resource; risks related to the company’s ability to secure necessary funding for project development; and potential changes in government policies or priorities affecting the critical minerals sector. The company cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company does not undertake any obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Contact Information:

Stephen Baghdadi
Managing Director
+61 2 9375 2353
info@datelineresources.com.au

Andrew Rowell
White Noise Communications
+61 400 466 226
andrew@whitenoisecomms.com

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

Innovative Asset Monitoring Technology Selected by U.S.’s Largest Container Chassis Provider

WATERLOO, ON / ACCESS Newswire / May 22, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) today announced that Direct ChassisLink, Inc. (“DCLI”), the largest provider of container chassis to the U.S. intermodal industry, will deploy BlackBerry® Radar® across 100,000 of its DCL53 domestic 53-foot chassis. The rollout is part of a major initiative DCLI is undertaking to enhance the quality, reliability, visibility and operational efficiency of its fleet, with a view to setting a new freight industry standard for data driven decision-making.

The deployment represents a deepening in the companies’ technological collaboration. DCLI has utilized Radar devices on a subset of its fleet for over five years and after seeing the reliability and intelligence they provide, decided to exponentially increase the number of its chassis deployed with the solution while also recognizing Radar as a top tier supplier.

With the BlackBerry Radar asset monitoring solution, DCLI will gain operational visibility, enabling its customers to optimize asset utilization and deliver more streamlined operations. Thanks to the steady stream of near real-time information Radar provides, DCLI will benefit from precise asset tracking, advanced inventory insights, location-based alerts, and optimized driver and terminal efficiency. Integrated sensors will streamline billing processes and enhance fleet optimization, enabling real-time monitoring of chassis to reduce delays and improve logistics planning.

The rollout of the technology also reinforces DCLI’s commitment to fleet safety and reliability by improving maintenance visibility and response times. This includes preparedness for chassis requiring FMCSA inspections, optimized maintenance scheduling, and enhanced responsiveness for road service – all measures that help minimize downtime, assist with compliance, and help create a safer operating environment for all stakeholders.

“At a time where the freight industry continues to grapple with driver shortages, rising costs, and supply chain disruptions, the need for advanced asset visibility with enhanced fleet management solutions has never been more important,” said Christopher Plaat, SVP and GM of BlackBerry Radar. “With the deployment of Radar, DCLI is taking a vital step in its digital transformation efforts. To that end, we’re excited to demonstrate the countless data-driven insights that can be unlocked when you have improved visibility into the status of your chassis. We look forward to continually improving our platform based on customer use cases and feedback.”

“At DCLI, quality is a top priority, and this initiative reflects our dedication to delivering exceptional value to our customers,” said Lee Newitt, chief executive officer at DCLI. “Equipping our entire DCL53 chassis fleet with GPS technology is a testament to our ongoing mission to lead the intermodal industry with innovative solutions and unparalleled fleet quality.”

BlackBerry Radar is an easy-to-install, asset monitoring solution for chassis, trailers, containers, and railcars, and provides near real-time information around location, cargo load status, motion, mileage, temperature, humidity, door open/close status, handbrake engaged status, and impact events through an intuitive dashboard. A device-agnostic platform that provides customers with a single pane of glass view for their asset management needs, with BlackBerry Radar, all data is transmitted and stored securely on a cloud platform, which maintains the privacy of user information at all times.

To find out more about BlackBerry Radar, visit www.blackberry.com/radar.

About BlackBerry

BlackBerry (NYSE:BB)(TSX: BB) provides enterprises and governments the intelligent software and services that power the world around us. Based in Waterloo, Ontario, the company’s high-performance foundational software enables major automakers and industrial giants alike to unlock transformative applications, drive new revenue streams and launch innovative business models, all without sacrificing safety, security, and reliability. With a deep heritage in Secure Communications, BlackBerry delivers operational resiliency with a comprehensive, highly secure, and extensively certified portfolio for mobile fortification, mission-critical communications, and critical events management.

©2025 BlackBerry Limited. Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, QNX and the QNX logo design are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.

About Direct ChassisLink, Inc. (“DCLI”)

DCLI is the largest provider of container chassis to the U.S. intermodal industry. Since 2009, when the company pioneered the exit of ocean carriers from the chassis business, we have generated consistent growth through expansion, acquisition, and innovation. We own, lease, and manage approx. 137,000 marine chassis and 152,000 domestic chassis with over 415 locations on or near key port facilities, depots, and intermodal hubs across the country. Since our founding, we have worked with motor carriers, ocean carriers, beneficial cargo owners, and domestic shippers to transform the way that chassis work within the intermodal supply chain. With a focus on equipment quality, operational efficiency, and delivering a great driver experience, our ultimate goal is to be the industry’s chassis partner of choice. To learn more about DCLI, please visit our website at www.dcli.com.

Media Contacts:

BlackBerry Media Relations
+1 (519) 597-7273
mediarelations@BlackBerry.com

DCLI Media Relations
Stacy Kirincic
AVP, Marketing
+1 (773) 793-0345
stacy.kirincic@dcli.com

Mike O’Malley
SVP Government and Public Relations, Human Resources
+1 (904) 314-2152
mike.omalley@dcli.com

SOURCE: BlackBerry Limited

View the original press release on ACCESS Newswire

Funding will be used for production and company growth in the US and abroad

INDIANAPOLIS, INDIANA / ACCESS Newswire / May 22, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, today announced that it has secured financial backing of up to $40 million from Streeterville Capital, LLC. Access to the capital coincided with Arrive AI’s public debut on Nasdaq on May15, 2025.

“This significant capital injection is one of the reasons we went to the public markets,” said Arrive AI CEO Dan O’Toole. “We celebrate the forward thinking Streeterville is leading with in their major commitment to our vision.”

Streeterville Capital is an investment firm with operations in Utah and Tennessee with investments in companies including Cingulate, the Marygold Companies and Damon Inc. Streeterville Capital President John Fife said he is intrigued with the vast potential of Arrive AI’s solution for package delivery issues like security and efficiency, and the cost savings that can be gleaned.

“This is an exciting answer to problems that are plaguing every industry. Dan and his crew really saw the future coming and worked quickly to meet needs that are starting to be seen around the world,” Fife said. “We’re excited to see how this plays out and are clearly bullish about Arrive AI.”

In 2014, O’Toole filed for his first patent for his concept of an AI-powered, smart mailbox capable of securely accepting packages delivered autonomously, beating similar filings from other potential competitors. Since then, he has built a global team, made multiple iterations and acquired complementary technology to refine the devices now known as “Arrive Points.” The company, which has amassed nearly 5,000 private investors and raised nearly $12 million, has largely generated capital via crowdsourcing. Now that Arrive AI is public a new chapter has begun.

-30-

About Arrive AI

Arrive AI‘s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com (http://www.arriveai.com/).

Media contact: Cheryl Reed, media@arriveai.com

Investor Relations Contact: Alliance Advisors IR, ARAI.IR@allianceadvisors.com

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements”

within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would”, “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

SOURCE: Arrive AI Inc.

View the original press release on ACCESS Newswire

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

The new FDA COVID Vaccine Booster Shots policy ^[1] is based on the findings that the groups that benefit from repeat of vaccination (i.e. booster shots) are the groups that are likely to be at risk of severe COVID disease from the virus. These groups include all adults over 65 years of age, and persons over 6 months of age that have one or more co-morbidity factors leading to a disposition towards severe COVID if infected.

The FDA policy notes that the benefit of repeat dosing of vaccine among people with low risk (i.e. healthy adults) is uncertain. As such, the FDA now will require randomized, placebo-controlled clinical trials that produce evidence of effectiveness in this healthy adults group if a vaccine is submitted for licensure to include this group.

In the past, the COVID vaccines were approved for all ages above 6 months. This resulted in CDC recommending the COVID vaccines for everyone. Yet, COVID vaccine uptake rate was only about 25% of the eligible persons in the last few years.

Over years of exposure, the population has built immunity due to multiple infections from ever-changing COVID variants as well as multiple vaccinations. An additional booster dose in such population would only make sense if a clear benefit can be proven.

“Evidence-based decision making about vaccine boosters policy for COVID is a welcome change over broadcast vaccine recommendation for all,” commented Anil R. Diwan, Ph.D., President and Executive Chairman of NanoViricides, adding, “This rational and scientific, non-dogmatic approach should go a long way towards restoring public trust in institutions that make decisions that affect peoples’ lives.”

The new policy brings the US FDA policy to be similar to the vaccination policies adopted in most developed countries. Even so, between 100 million to 200 million Americans are estimated to be eligible for boosters because of the broad definition for co-morbidity factors that put a person at high risk of severe COVID, which include obesity, diabetes, asthma, and even mood disorders.

“We believe that when a highly effective antiviral drug against COVID becomes available, the need for vaccination will decrease substantially,” said Dr. Diwan, adding, “Our broad-spectrum antiviral drug NV-387 is poised to become an important solution for multiple viral threats that emerge every season, including Influenzas, Coronaviruses, RSV, MPox, and possibly even Measles!”

About NanoViricides

NanoViricides, Inc. (the “Company”) ( www.nanoviricides.com ) is a clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.

The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

NV-CoV-2 (API NV-387) is our nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is our other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. The Company believes that since remdesivir is already US FDA approved, our drug candidate encapsulating remdesivir is likely to be an approvable drug, if safety is comparable. Remdesivir is developed by Gilead. The Company has developed both of its own drug candidates NV-CoV-2 and NV-CoV-2-R independently.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

The phrases “safety”, “effectiveness” and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA.

FDA refers to US Food and Drug Administration. IND application refers to “Investigational New Drug” application. cGMP refers to current Good Manufacturing Practices. CMC refers to “Chemistry, Manufacture, and Controls”. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency’s (EMA) committee responsible for human medicines. API stands for “Active Pharmaceutical Ingredient”. WHO is the World Health Organization. R&D refers to Research and Development.

Contact:
NanoViricides, Inc.
info@nanoviricides.com

Public Relations Contact:
ir@nanoviricides.com

---

^[1] Vinay Prasad, M.D., M.P.H., and Martin A. Makary, M.D., M.P.H. “An Evidence-Based Approach to Covid-19 Vaccination”, New England J Med., published May 20, 20

SOURCE: NanoViricides, Inc.

View the original press release on ACCESS Newswire